Our Chairman of the Board, Dr. Ali İhsan Şerbetçi Shared His Views on the Turkish Vaccine Industry on APara Channel on 23 December 2020
Our Chairman of the Board, Dr. Ali İhsan Şerbetçi Shared His Views on the Turkish Vaccine Industry on APara Channel on 23 December 2020
Recently Added News
Our Chairman of the Board of Directors Dr. Ali İhsan Şerbetçi gave information about the production of syringes in the Covid19 vaccination process in the Bloomberg HT Channel Fokus program.
Our Chairman of the Board of Directors Dr. Ali İhsan Şerbetçi gave information about the production of syringes in the Covid19 vaccination process in the Bloomberg HT Channel Fokus program.
Detail
As the first Turkish company to receive syringe clearance from FDA, we increased our production capacity to 1 billion units.
As the first Turkish company to receive syringe clearance from FDA, we increased our production capacity to 1 billion units.
Detail